Breast Cancer :: Why are African American women more likely than whites to die from breast cancer?
Why are African American women 1.5 to 2.2 times more likely than White women to die from breast cancer, despite their lower incidence of the disease?
Breast cancer
Breast Cancer :: Protein identified that regulates effectiveness of Taxol chemotherapy in breast cancer
Cancer researchers at Georgetown University Medical Center have taken a step towards understanding how and why a widely used chemotherapy drug works in patients with breast cancer.
Breast Cancer :: A black and white look at breast cancer mortality
Researchers suggest a reason for racial disparity in breast cancer survival rates. African and African American women are much less likely to survive breast cancer surgery than their white counterparts and far more likely to get the disease before the menopause. Previous research suggests that those who undergo surgery for the disease before the menopause are more prone to relapse.
Breast Cancer :: Tamoxifen yields long-term reduction in breast cancer risk
Tamoxifen offers long-term benefits for breast cancer prevention among women at high risk of the disease, according to two randomized, blinded clinical trials in the February 21 Journal of the National Cancer Institute. The trials found that the breast cancer risk reduction persists long after women stop taking tamoxifen.
Breast Cancer :: Gene profiling predicts resistance to breast cancer drug Herceptin
Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer.
Breast Cancer :: Exercise improves quality of life for people with breast cancer
Group exercise sessions can help to improve the physical and psychological wellbeing of people diagnosed with breast cancer, a new BMJ study reveals today.
Breast Cancer :: Gene expression test reveals ER and HER-2 status of breast tumors
Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online.
Breast Cancer :: Breast cancer survival rates improved by novel drug sequence
Changing the way women are treated for breast cancer could improve their overall chance of survival, according to research published today in the Lancet. The new paper shows that switching to a drug called exemestane, two to three years after commencing standard therapy with the drug tamoxifen, can cut the risk of death for certain women by a further 17 percent compared with using tamoxifen alone.
Breast Cancer :: Early switch to an aromatase inhibitor increases survival
For breast cancer patients taking tamoxifen, switching to an aromatase inhibitor within three years significantly improves survival rates, according to a new study.
Breast Cancer :: Emerging research heralds new era of breast cancer management
Aggressive research currently underway brings hope of dramatic advances in breast cancer management, according to a new review.